logo

Rumi Scientific

Rumi Scientific's mission is to fast-track the early stage of drug discovery using our predictive models of the human brain for therapeutic success. Many neurodevelopmental diseases do not have treatments due to a lack of a-priori knowledge of the underlying biology. Rumi Scientific's technology is able to model these diseases to help enable the discovery of new targets and drugs, de-risking the current failure-prone cumbersome approach.
For inquiries, please contact us at
E-mail: info@rumiscientific.com
 

Ilse Daehn

Ilse Daehn, Ph.D., SAB Member

 

Dr. Ilse Daehn is a molecular and cell biologist with expertise in DNA damage and oxidative stress. She obtained her undergraduate in Biotechnology (Honors) and was awarded her Ph.D from the Flinders University of South Australia in 2008. She then pursued a postdoctoral fellowship at Cancer Research UK, London before joining the Icahn School of Medicine at Mount Sinai in 2010. She became faculty at the Icahn School of Medicine at Mount Sinai in 2013. Her primary research interests are to understand the early molecular events involving mitochondria that occur and lead to chronic kidney disease. Her work has provided a fundamental paradigm shift in our current understanding of chronic kidney disease development and is now applying this knowledge to seek for biomarkers in the urine for early detection of disease and its progression. Dr. Daehn is also interested in exploring and evaluating the genetic susceptibility of individuals in the community to developing progressive kidney disease.


I would like to learn about Rumi Scientific’s novel discoveries to treat genetic diseases.